0001689048-18-000001.txt : 20181004 0001689048-18-000001.hdr.sgml : 20181004 20181004113313 ACCESSION NUMBER: 0001689048-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181004 DATE AS OF CHANGE: 20181004 EFFECTIVENESS DATE: 20181004 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Confluence Pharmaceuticals LLC CENTRAL INDEX KEY: 0001689048 IRS NUMBER: 272967477 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-322791 FILM NUMBER: 181107310 BUSINESS ADDRESS: STREET 1: 4904 DEER RIDGE DRIVE SOUTH CITY: CARMEL STATE: IN ZIP: 46033 BUSINESS PHONE: (317) 379-7498 MAIL ADDRESS: STREET 1: 4904 DEER RIDGE DRIVE SOUTH CITY: CARMEL STATE: IN ZIP: 46033 D 1 primary_doc.xml X0708 D LIVE 0001689048 Confluence Pharmaceuticals LLC 4904 DEER RIDGE DRIVE SOUTH CARMEL IN INDIANA 46033 (317) 379-7498 INDIANA None None Limited Liability Company true Steven L. Johns 4904 Deer Ridge Drive South Carmel IN INDIANA 46033 Executive Officer Director President, CEO and Manager of the Issuer Boyd W. Sturdevant, Jr. 8033 N. Lakeview Drive Unionville IN INDIANA 47468 Director Manager of the Issuer Phil Lodato 50 E. 91st Street, #213 Indianapolis IN INDIANA 46240 Director Manager of the Issuer Pharmaceuticals Decline to Disclose 06b false 2018-09-17 false true true Promissory notes convertible into preferred units false 10000 800000 10000 790000 false 1 0 0 0 false Confluence Pharmaceuticals LLC /s/ Steven L. Johns Steven L. Johns President and Chief Executive Officer 2018-10-03